Dellwood Farms Inc v. Cargill Inc ( 2002 )


Menu:
  •                            In the
    United States Court of Appeals
    For the Seventh Circuit
    ____________
    No. 01-3565
    IN RE HIGH FRUCTOSE CORN SYRUP ANTITRUST LITIGATION.
    APPEAL OF A & W BOTTLING, INC., et al.
    ____________
    Appeal from the United States District Court
    for the Central District of Illinois.
    No. 95 C 1477, MDL 1087—Michael M. Mihm, Judge.
    ____________
    ARGUED MAY 17, 2002—DECIDED JUNE 18, 2002
    ____________
    Before BAUER, POSNER, and KANNE, Circuit Judges.
    POSNER, Circuit Judge. The plaintiffs appeal from the grant
    of summary judgment to the defendants in an antitrust class
    action charging price fixing in violation of section 1 of the
    Sherman Act, 15 U.S.C. § 1. 
    156 F. Supp. 2d 1017
    (C.D. Ill.
    2001). The defendants are the principal manufacturers of
    high fructose corn syrup (HFCS)—Archer Daniels Midland
    (ADM), A.E. Staley, Cargill, American Maize-Products, and
    CPC International (which has settled with the plaintiffs,
    however, and thus is no longer a party). The plaintiffs rep-
    resent a certified class consisting of direct purchasers from
    the defendants.
    HFCS is a sweetener manufactured from corn and used in
    soft drinks and other food products. There are two grades,
    HFCS 42 and HFCS 55, the numbers referring to the percent-
    2                                                  No. 01-3565
    age of fructose. HFCS 55, which constitutes about 60 percent
    of total sales of HFCS, is bought mostly by producers of soft
    drinks, with Coca-Cola and Pepsi-Cola between them ac-
    counting for about half the purchases. But many purchasers,
    of both grades of HFCS, are small. Industry sales exceeded
    $1 billion a year during the relevant period.
    The plaintiffs claim that in 1988 the defendants secretly
    agreed to raise the prices of HFCS, that the conspiracy was
    implemented the following year, and that it continued until
    mid-1995 when the FBI raided ADM in search of evidence
    of another price-fixing conspiracy. Billions of dollars in tre-
    ble damages are sought; we do not know whether the plain-
    tiffs are also seeking injunctive relief, whether against re-
    newal of the conspiracy, specific practices left in its wake
    (such as the 90 percent rule, of which more shortly), or
    both. The suit was brought in 1995 and though an enormous
    amount of evidence was amassed in pretrial discovery, the
    district judge concluded that “no reasonable jury could find
    in [the plaintiffs’] favor on the record presented in this case
    without resorting to pure speculation or conjecture.” The
    soundness of this conclusion is the basic issue presented by
    the appeal.
    Section 1 of the Sherman Act forbids contracts, combina-
    tions, or conspiracies in restraint of trade. This statutory lan-
    guage is broad enough, as we noted in JTC Petroleum Co. v.
    Piasa Motor Fuels, Inc., 
    190 F.3d 775
    , 780 (7th Cir. 1999), to
    encompass a purely tacit agreement to fix prices, that is,
    an agreement made without any actual communication
    among the parties to the agreement. If a firm raises price
    in the expectation that its competitors will do likewise, and
    they do, the firm’s behavior can be conceptualized as the
    offer of a unilateral contract that the offerees accept by rais-
    ing their prices. Or as the creation of a contract implied in
    fact. “Suppose a person walks into a store and takes a news-
    No. 01-3565                                                     3
    paper that is for sale there, intending to pay for it. The
    circumstances would create a contract implied in fact” even
    though there was no communication between the parties.
    A.E.I. Music Network, Inc. v. Business Computers, Inc., No. 01-
    1650, 
    2002 WL 1033947
    , at *3 (7th Cir. May 22, 2002). Nev-
    ertheless it is generally believed, and the plaintiffs implicitly
    accept, that an express, manifested agreement, and thus
    an agreement involving actual, verbalized communication,
    must be proved in order for a price-fixing conspiracy to be
    actionable under the Sherman Act. See, e.g., Reserve Supply
    Corp. v. Owens-Corning Fiberglas Corp., 
    971 F.2d 37
    , 50-51
    (7th Cir. 1992); Rebel Oil Co. v. Atlantic Richfield Co., 
    51 F.3d 1421
    , 1443 (9th Cir. 1995); Clamp-All Corp. v. Cast Iron Soil
    Pipe Institute, 
    851 F.2d 478
    , 484 (1st Cir. 1988); E.I. Du Pont de
    Nemours & Co. v. FTC, 
    729 F.2d 128
    , 139 (2d Cir. 1984); John
    E. Lopatka, “Solving the Oligopoly Problem: Turner’s Try,”
    41 Antitrust Bull. 843, 896-903 (1996).
    Because price fixing is a per se violation of the Sherman
    Act, an admission by the defendants that they agreed to fix
    their prices is all the proof a plaintiff needs. In the absence
    of such an admission, the plaintiff must present evidence
    from which the existence of such an agreement can be in-
    ferred—and remember that the plaintiffs in this case con-
    cede that it must be an explicit, manifested agreement rather
    than a purely tacit meeting of the minds. The evidence up-
    on which a plaintiff will rely will usually be and in this case
    is of two types—economic evidence suggesting that the de-
    fendants were not in fact competing, and noneconomic
    evidence suggesting that they were not competing because
    they had agreed not to compete. The economic evidence will
    in turn generally be of two types, and is in this case: evi-
    dence that the structure of the market was such as to make
    secret price fixing feasible (almost any market can be car-
    telized if the law permits sellers to establish formal,
    overt mechanisms for colluding, such as exclusive sales
    4                                                 No. 01-3565
    agencies); and evidence that the market behaved in a
    noncompetitive manner. Neither form of economic evidence
    is strictly necessary, see United States v. Andreas, 
    216 F.3d 645
    , 666 (7th Cir. 2000), since price-fixing agreements are
    illegal even if the parties were completely unrealistic in sup-
    posing they could influence the market price. But economic
    evidence is important in a case such as this in which, al-
    though there is noneconomic evidence, that evidence is
    suggestive rather than conclusive.
    In deciding whether there is enough evidence of price
    fixing to create a jury issue, a court asked to dismiss a price-
    fixing suit on summary judgment must be careful to avoid
    three traps that the defendants in this case have cleverly laid
    in their brief. The first is to weigh conflicting evidence
    (the job of the jury), and is illustrated by a dispute between
    the parties over testimony by an executive of A.E. Staley
    that Coca-Cola, a major customer, suggested that the prices
    of HFCS 42 and HFCS 55 be fixed in a ratio of 9 to 10. The
    fact that the defendants all adopted this ratio is part of the
    plaintiffs’ evidence of conspiracy, and the inference of con-
    spiracy would be weakened if the initiative for the adoption
    had come from a customer. The defendants treat the Staley
    testimony as uncontradicted because Coca-Cola’s witness
    did not deny having suggested the 9:10 ratio but instead
    testified that he didn’t recall having suggested it and was
    not aware of his company’s ever having such a preference.
    The absence of a flat denial by Coca-Cola’s witness of the
    Staley testimony would not as the defendants contend re-
    quire a reasonable jury to accept that testimony, which is
    self-serving, uncorroborated, implausible (because the de-
    fendants achieved the ratio by raising the price of HFCS
    42 rather than by lowering the price of HFCS 55, so Coca-
    Cola could not have benefited unless it just bought 55 and
    a competitor 42, which is not suggested), and inconsistent
    with the overall evidence of conspiracy, which as we shall
    No. 01-3565                                                    5
    see was abundant although not conclusive. A plaintiff can-
    not make his case just by asking the jury to disbelieve the
    defendant’s witnesses, but there is much more here. The
    defendants’ handling of the 90 percent issue illustrates how
    the statement of facts in the defendants’ brief combines a
    recital of the facts favorable to the defendants with an in-
    terpretation favorable to them of the remaining evidence;
    and that is the character of a trial brief rather than of a brief
    defending a grant of summary judgment.
    The second trap to be avoided in evaluating evidence
    of an antitrust conspiracy for purposes of ruling on the
    defendants’ motion for summary judgment is to suppose
    that if no single item of evidence presented by the plaintiff
    points unequivocally to conspiracy, the evidence as a whole
    cannot defeat summary judgment. It is true that zero plus
    zero equals zero. But evidence can be susceptible of differ-
    ent interpretations, only one of which supports the party
    sponsoring it, without being wholly devoid of probative
    value for that party. Otherwise what need would there ever
    be for a trial? The question for the jury in a case such as this
    would simply be whether, when the evidence was consid-
    ered as a whole, it was more likely that the defendants had
    conspired to fix prices than that they had not conspired to
    fix prices. E.g., In re Brand Name Prescription Drugs Antitrust
    Litigation, 
    186 F.3d 781
    , 787 (7th Cir. 1999).
    The third trap is failing to distinguish between the ex-
    istence of a conspiracy and its efficacy. The defendants point
    out that many of the actual sales of HFCS during the period
    of the alleged conspiracy were made at prices below the
    defendants’ list prices, and they intimate, without quite
    saying outright, that therefore even a bald-faced agreement
    to fix list prices would not be illegal in this industry. (Their
    brief states, for example, that “list prices are irrelevant here
    because the vast majority of HFCS sales were not made at
    6                                                 No. 01-3565
    list price” (emphasis in original).) That is wrong. An agree-
    ment to fix list prices is, as the defendants’ able counsel
    reluctantly conceded at the argument of the appeal, a per se
    violation of the Sherman Act even if most or for that matter
    all transactions occur at lower prices. Anyway sellers would
    not bother to fix list prices if they thought there would be
    no effect on transaction prices. Many sellers are blessed
    with customers who are “sleepers,” that is, customers who
    don’t shop around for the best buy; and even for those who
    do bargain for a lower price, the list price is usually the
    starting point for the bargaining and the higher it is (with-
    in reason) the higher the ultimately bargained price is like-
    ly to be. The defendants acknowledge that their “price lists
    served a useful purpose.” The only useful purpose they
    might serve is as a guide to likely transaction prices. What
    is true is that if many sales are made at prices below the
    list price, the fact that the sellers’ list prices are the same
    is not compelling proof of collusion. See Reserve Supply
    Corp. v. Owens-Corning Fiberglas 
    Corp., supra
    , 971 F.2d at 53-
    54. But it wouldn’t be anyway, since identical list prices
    might be adopted by imitation rather than by explicit agree-
    ment.
    Let us turn to the evidence that the HFCS market is one
    in which secret price fixing might actually have an effect
    on price and thus be worth attempting. The fact that price
    fixing has to be kept secret in order to avoid immediate
    detection followed promptly by punishment tends to rule
    out price fixing in markets that have many sellers selling
    a product heterogeneous with regard to quality and specifi-
    cations and having good substitutes in production or con-
    sumption; that are concentrated on the buying side, en-
    abling the buyers to tempt sellers to shade any agreed-upon
    price in order to obtain a big bloc of business; and that have
    other characteristics, unnecessary to detail here, that make
    No. 01-3565                                                  7
    it irrational to run the legal and business risks of fixing
    prices.
    The plaintiffs’ economic expert opined in his report and
    the defendants pretty much concede that the structure of
    the HFCS market, far from being inimical to secret price
    fixing, is favorable to it. We need not go into great detail on
    the point as it is not seriously contested. There are few
    sellers of HFCS. The five original defendants (recall that one
    has now settled with the plaintiffs) accounted during the
    period of the alleged conspiracy for 90 percent of the sales
    of the product. Therefore elaborate communications, quick
    to be detected, would not have been necessary to enable
    pricing to be coordinated. And if one seller broke ranks, the
    others would quickly discover the fact, and so the seller
    would have gained little from cheating on his coconspir-
    ators; the threat of such discovery tends to shore up a cartel.
    In addition, the product, HFCS, is highly standardized.
    Remember that there are only two grades, 42 and 55; and
    both are uniform. So colluding sellers would not have to
    agree not only on price but also on quality, design, post-sale
    services, and the like. This is another reason why a success-
    ful conspiracy would not require such frequent communica-
    tions as to make prompt detection likely. There also are no
    close substitutes for HFCS. Not that there aren’t plenty of
    other sweeteners, such as sugar; but apparently they are not
    perceived as close substitutes by soft-drink manufacturers
    and other purchasers of HFCS. An attempt to raise price
    above cost would not be likely to come to grief by causing
    a hemorrhage of business to sellers in other markets.
    And the defendants had a lot of excess capacity, a condi-
    tion that makes price competition more than usually risky
    and collusion more than usually attractive. When a market’s
    productive capacity exceeds the demand for the market’s
    product, a very low price will cover the incremental cost
    8                                                 No. 01-3565
    of additional output because capacity will not have to be
    expanded in order to enable additional production. Compe-
    tition will tend to drive price down to that level because any
    price above it will make some contribution to the seller’s
    fixed costs (the costs that do not vary with output, such as
    the cost of building the seller’s plant). But it will not be
    remunerative pricing, because it will not cover those costs
    in full. A seller might have a huge debt (a fixed cost, be-
    cause owed regardless of how much the seller produces)
    because of its huge underutilized plant and yet find it im-
    possible to service the debt because competition from other
    firms also cursed with excess capacity and so also desperate
    to find buyers who will pay a price that makes some contri-
    bution to their heavy fixed costs had driven its price down
    to, or very near, the incremental cost of its output. Suppose
    for example that the average total cost of some quantity X
    of HFCS is $10, but the incremental cost required to sell X
    more of HFCS is only $5. Then at any price above $5, even
    if it is below $10, a sale will make some contribution to cov-
    ering the seller’s fixed costs. If several sellers with similar
    cost structures are competing, the tendency will be to drive
    the market price all the way down to $5, which will prevent
    the sellers from covering their total costs and thus confront
    them with the risk of bankruptcy. Conversely, precisely
    because of the discrepancy between total and variable cost,
    an agreement among the sellers that eliminates price com-
    petition will generate revenues enormously in excess of
    variable cost and so go far to stave off the threat of bank-
    ruptcy. And so the sellers will have a big incentive to fix
    prices.
    As our numerical example suggests, the significance of
    excess capacity depends on the ratio of fixed to variable
    costs. If it is very low, the impact on the firms’ solvency of
    competition that forces price down to variable costs may be
    slight. This is so far an unexplored issue in the litigation.
    No. 01-3565                                                  9
    The defendants continued to add to their capacity during
    the period of the alleged conspiracy. This behavior does not
    disprove the existence of the conspiracy, as the defendants
    argue. Maintenance of excess capacity discourages new
    entry, which supracompetitive prices would otherwise at-
    tract, and also shores up a cartel by increasing the risk
    that its collapse will lead to a devastating price war ending
    in the bankruptcy of some or all of the former cartelists.
    The principal features of the HFCS market that might
    seem to bear against an inference that secret price fixing was
    feasible and attractive during the period of the alleged con-
    spiracy are, first, that HFCS is sold under two different
    types of contract: straight sale, and what are called “tolling
    agreements.” Under the latter, the customer buys the corn
    and hires one of the sellers of HFCS to manufacture it into
    HFCS. That sounds like something that would greatly
    complicate an HFCS price-fixing conspiracy, but there is
    evidence that it did not. It seems that the only practical dif-
    ference between the two forms of sale is that the tolling
    agreement shifts the risk of a change in the raw-material
    cost (the cost of the corn) from seller to buyer. Prices under
    the two arrangements are highly correlated and the price
    of the HFCS net of the cost of the corn is easily determined,
    so that sellers could not easily cheat on a price-fixing agree-
    ment by reducing the price of their tolling contracts.
    Second, there are some very large buyers of HFCS, nota-
    bly Coca-Cola and Pepsi-Cola, and, as theory predicts, they
    drove hard bargains and obtained large discounts from
    the list price of HFCS 55. But it does not follow that the
    defendants could not and did not fix the price of HFCS 55.
    There is a difference between a market in which all or vir-
    tually all the buyers are large and one in which there are
    some large and some small buyers. Suppose the buying side
    of the HFCS market were as concentrated as the selling side,
    10                                                   No. 01-3565
    meaning that five firms bought 90 percent of all the HFCS
    sold. They would be able to whipsaw the sellers into grant-
    ing large discounts, and probably therefore any effort at
    fixing prices would quickly collapse. When instead there
    are some large and some small buyers, which is the situa-
    tion here, this need not prevent price fixing; it may simply
    cause the price fixers to engage in price discrimination,
    giving large discounts to the big buyers and no (or small)
    discounts to the small ones.
    Market-wide price discrimination is a symptom of price
    fixing when, as in this case, the product sold by the market
    is uniform. In re Brand Name Prescription Drug Antitrust
    Litigation, 
    288 F.3d 1028
    , 1030-31 (7th Cir. 2002). If the prod-
    uct is differentiated and as a result each seller has a little
    pocket of monopoly power, enabling it to charge some of its
    customers a price above cost without their switching to its
    competitors, no inference of collusion can be drawn from
    the fact that the sellers are all discriminating. 
    Id. In this
    case,
    however, the product is uniform (a “commodity”), so that
    competition would be expected to prevent any one seller
    from raising his price to any of his customers above his cost.
    If sellers are competing in the sale of an identical product
    which costs each of them $1 to produce (including in cost
    the market return on equity capital, “profit” in a financial
    though not in an economic sense), so that the competitive
    price, which is the market price because the sellers are com-
    peting, is $1, no one of them can sell his product to some
    of his customers for $2, for they can buy from his competi-
    tors for $1—unless the sellers collude, and agree not to cut
    price to the disfavored buyers. This is a highly simplified
    example, obviously. It ignores and the parties do not discuss
    the possible erosion of price discrimination by arbitrage,
    that is, by the favored buyers’ buying more than they need
    and reselling the excess to the disfavored, a process that
    may continue until all buyers obtain the seller’s product
    No. 01-3565                                                 11
    at the same price. 
    Id. But the
    example does illustrate an
    economic logic that favors the plaintiffs.
    We turn now to the evidence of noncompetitive behavior,
    as distinct from evidence that the structure of the market
    was conducive to such behavior. Early in 1988, which is to
    say at the outset of the alleged conspiracy, ADM announced
    that it was raising its price for HFCS 42 to 90 percent of
    the price of HFCS 55, and the other defendants quickly
    followed suit. The defendants offer various explanations,
    of which the most plausible is that HFCS 42 is 90 percent
    as sweet as HFCS 55. Even if this is correct (there is evi-
    dence that the true percentage is only 71 percent), it does
    not counter an inference of price fixing. In a competitive
    market, price is based on cost rather than on value. There-
    fore the fact that buyers of HFCS are willing to pay more
    for HFCS 55 than for HFCS 42 because it is sweeter just
    shows that a monopolist or cartel could charge more for the
    higher grade whereas competition would bid price down
    to cost. (That was our $1-$2 example; the fact that some cus-
    tomers would pay $2 did not make that a competitive price.)
    Under competition, if the cost of the lower grade were, say,
    half the cost of the higher, so would the price be. There is
    no evidence that HFCS 42 costs 90 percent as much to pro-
    duce as HFCS 55. Nor is there any evidence that industry-
    wide adoption of the 90 percent rule followed or anticipated
    a change in relative costs. In fact, the evidence suggests that
    it costs only 65 percent as much to manufacture HFCS 42,
    implying that under competition its price would be 65
    percent—not 90 percent—of the price of HFCS 55.
    A few months after the adoption of the 90 percent rule, the
    defendants switched from making contracts with their cus-
    tomers that specified the contract price for an entire year
    to contracts in which price was negotiated quarterly. They
    did this although virtually all their customers preferred
    12                                               No. 01-3565
    the former system in order to minimize risk. In other words,
    the defendants shifted risk to their customers (the sort of
    thing the tolling agreements did for customers who bought
    under those agreements) at the same time that, according to
    evidence discussed below, the defendants were raising their
    prices net of cost, rather than lowering them to compensate
    the customers for assuming additional risk. That is not com-
    petitive behavior.
    There is evidence that defendants bought HFCS from one
    another even when the defendant doing the buying could
    have produced the amount bought at a lower cost than the
    purchase price. There is nothing suspicious about a firm’s
    occasionally buying from a competitor to supply a customer
    whom the firm for one reason or another can’t at the mo-
    ment supply. The firm would rather buy from a competitor
    to supply its customer than tell the customer to buy from
    the competitor, lest the customer never return. But if the
    firm could supply its customer (remember there was a lot
    of excess capacity in the HFCS industry during the period
    of the alleged conspiracy) and at a lower cost than its com-
    petitor would charge, why would it buy from the competi-
    tor rather than expanding its own production? The possibil-
    ity that springs immediately to mind is that this is a way
    of shoring up a sellers’ cartel by protecting the market
    share of each seller. A seller who experiences a surge in de-
    mand, but meets the surge by buying what it needs from
    another seller rather than by expanding its own produc-
    tion, protects the other firm’s market share and so preserves
    peace among the cartelists. It is pertinent to note that these
    inter-competitor transactions ended with the end of the al-
    leged conspiracy.
    In part because of those transactions the market shares
    of the defendants changed very little during the period
    of the alleged conspiracy, which is just what one would
    No. 01-3565                                                13
    expect of a group of sellers who are all charging the same
    prices for a uniform product and trying to keep everyone
    happy by maintaining the relative sales positions of the
    group’s members. This evidence probably does not deserve
    as much weight as the plaintiffs give it. They don’t point us
    to any evidence of how market shares fluctuated before or
    after the period of the alleged conspiracy; and without such
    evidence there is no benchmark against which to assess the
    stability of the defendants’ market shares during that peri-
    od. But it is something, the evidence of stable market shares,
    for two reasons. First, had they gyrated wildly, this would
    be some evidence of active competition. The defendants ar-
    gue that they did gyrate wildly, but their evidence involves
    comparing pre-conspiracy (1988) market shares with market
    shares during the period of the alleged conspiracy (the
    district court followed them in this mistake). If, consistent
    with that evidence, the gyrations moderated during the
    period of the alleged conspiracy, this would be evidence for
    the plaintiffs.
    Second and much more important, the output of HFCS
    grew during this period and one might expect that growth
    to have brought about changes in market shares; for it
    would be unlikely that all the sellers had the same abil-
    ity to exploit the new sales opportunities opened by the
    growing demand. This is why a growth in demand usually
    makes it more difficult for a cartel to hold together than
    if demand is steady. If demand is growing it is difficult for
    a seller to determine whether a decline in its market share
    is due to cheating by another member of the cartel or just
    to the superior ability of some other member or members
    of the cartel to attract new business without cutting price.
    The defendants emphasize that point but fail to acknowl-
    edge that the fact that market shares did not fluctuate
    significantly during the period of the alleged HFCS con-
    spiracy may indicate that the sellers had agreed tacitly or
    14                                                 No. 01-3565
    otherwise to share the sales opportunities created by the
    growth in demand. This is conjecture, but conjecture has its
    place in building a case out of circumstantial evidence.
    The plaintiffs’ economic expert witness conducted a re-
    gression analysis that found, after correcting for other fac-
    tors likely to influence prices of HFCS, that those prices
    were higher during the period of the alleged conspiracy
    than they were before or after. (More precisely, the indepen-
    dent variable that the expert labeled CONSPIRE, which
    took a value of 1 during the period of the alleged conspir-
    acy and a value of 0 before and after that period, was found
    to have a positive and statistically significant effect on the
    dependent variable, which was price.) The judge deemed
    the analysis admissible as evidence, thus certifying it as the
    responsible though of course not necessarily correct work
    of a qualified professional. See Daubert v. Merrell Dow Phar-
    maceuticals, Inc., 
    509 U.S. 579
    , 592-95 (1993). The defen-
    dants presented a competing regression analysis done by
    one of their economic experts, who added a couple of vari-
    ables to the analysis of the plaintiffs’ expert and, presto, the
    CONSPIRE variable ceased to be statistically significant. The
    plaintiffs rebutted with still another expert, who pointed out
    correctly that adding variables that are correlated with the
    variable of interest can make the effect of the latter disap-
    pear—to which the defendants reply, also correctly, that
    there are statistical methods for solving this problem (the
    problem of multicollinearity, as it is called by statisticians).
    They argue that their expert solved it and the plaintiffs ar-
    gue that he did not and also that there was no statistical
    rationale for adding those other variables in the first place.
    Resolving this dispute requires a knowledge of statistical
    inference that judges do not possess. Later we’ll suggest a
    method for resolving it. But in the present state of the record
    we must accept that the plaintiffs have presented some ad-
    missible evidence that higher prices during the period of the
    No. 01-3565                                                  15
    alleged conspiracy cannot be fully explained by causes con-
    sistent with active competition, such as changes in the price
    of corn. For the same reason, we are disinclined to second
    guess, as the plaintiffs invite us to do, the district judge’s
    refusal to exclude under the Daubert standard the reports of
    the defendants’ experts.
    To summarize the discussion to this point, there is evi-
    dence both that the HFCS market has a structure that is
    auspicious for price fixing and that during the period of the
    alleged conspiracy the defendants avoided or at least lim-
    ited price competition. But as the defendants point out
    (when they are not arguing, inconsistently, that the industry
    was in fact fiercely competitive), all of this evidence is con-
    sistent with the hypothesis that they had a merely tacit
    agreement, which at least for purposes of this appeal the
    plaintiffs concede is not actionable under section 1 of the
    Sherman Act. The question then becomes whether there is
    enough evidence for a reasonable jury to find that there was
    an explicit agreement, not merely a tacit one. To repeat,
    there is evidence that the defendants were not competing;
    we might go so far as to say they had tacitly agreed not to
    compete, or at least to compete as little as possible; but the
    plaintiffs must prove that there was an actual, manifest
    agreement not to compete. Another and equivalent way to
    put this is that they must present evidence that would en-
    able a reasonable jury to reject the hypothesis that the
    defendants foreswore price competition without actually
    agreeing to do so. See, e.g., Matsushita Electric Industrial Co.
    v. Zenith Radio Corp., 
    475 U.S. 574
    , 588 (1986).
    More evidence is required the less plausible the charge of
    collusive conduct. In Matsushita, for example, the charge
    was that the defendants had conspired to lower prices be-
    low cost in order to drive out competitors, and then to raise
    prices to monopoly levels. This was implausible for a vari-
    16                                                No. 01-3565
    ety of reasons, such as that it would mean that losses would
    be incurred in the near term in exchange for the speculative
    possibility of more than making them up in the uncertain
    and perhaps remote future—when, moreover, the competi-
    tors might come right back into the market as soon as (or
    shortly after) prices rose above cost, thus thwarting the con-
    spirators’ effort at recouping their losses with a commensu-
    rate profit. But the charge in this case involves no implausi-
    bility. The charge is of a garden-variety price-fixing conspir-
    acy orchestrated by a firm, ADM, conceded to have fixed
    prices on related products (lysine and citric acid) during a
    period overlapping the period of the alleged conspiracy to
    fix the prices of HFCS. See United States v. 
    Andreas, supra
    ,
    216 F.3d at 650-54; In re Citric Acid Litigation, 
    996 F. Supp. 951
    , 953-54 (N.D. Cal. 1998), aff’d, 
    191 F.3d 1090
    (9th Cir.
    1999).
    We shall now summarize the evidence of explicit agree-
    ment, first noting however that the district judge refused to
    consider any of this evidence because he thought its charac-
    ter was such as to “require that a substantial inference be
    drawn in order to have evidentiary significance.” This is
    correct in the sense that no single piece of the evidence that
    we’re about to summarize is sufficient in itself to prove a
    price-fixing conspiracy. But that is not the question. The
    question is simply whether this evidence, considered as a
    whole and in combination with the economic evidence, is
    sufficient to defeat summary judgment. The judge may have
    been confused by the language found in cases such as In re
    Baby Food Antitrust Litigation, 
    166 F.3d 112
    , 118 (3d Cir.
    1999), that “direct evidence in a Section 1 conspiracy must
    be evidence that is explicit and requires no inferences to
    establish the proposition or conclusion being asserted.” We
    tried in Troupe v. May Department Stores Co., 
    20 F.3d 734
    , 736-
    37 (7th Cir. 1994), to straighten out the confusing (and, as it
    seems to us, largely if not entirely superfluous) distinction
    No. 01-3565                                                   17
    between direct and circumstantial evidence. The former is
    evidence tantamount to an acknowledgment of guilt; the
    latter is everything else including ambiguous statements.
    These are not to be disregarded because of their ambiguity;
    most cases are constructed out of a tissue of such statements
    and other circumstantial evidence, since an outright confes-
    sion will ordinarily obviate the need for a trial.
    Here at any rate is the plaintiffs’ evidence, which the
    district judge should not have disregarded, that there was
    an explicit agreement to fix prices: One of Staley’s HFCS
    plant managers was heard to say: “We have an understand-
    ing within the industry not to undercut each other’s prices.”
    (He was commenting on a matter within the scope of his
    employment and his comment was therefore admissible as
    an admission by a party. Fed. R. Evid. 801(d)(2)(D).) A
    Staley document states that Staley will “support efforts to
    limit [HFCS] pricing to a quarterly basis.” Presumably the
    reference is to efforts by its competitors. The president of
    ADM stated that “our competitors are our friends. Our cus-
    tomers are the enemy.” This sentiment, which will win no
    friends for capitalism, was echoed by a director of Staley’s
    parent company who said in a memo to Staley executives
    that “competitors[’] happiness is at least as important as
    customers[’] happiness.” A director of Staley was reported
    to have said that “every business I’m in is an organization”
    (emphasis added)—which sounds innocuous enough, but he
    said it in reference to the conspiracy to fix the price of lysine
    (“lysine is an organization”) and so in context it appears
    that “organization” meant price-fixing conspiracy. Michael
    Andreas, the vice chairman and executive vice president
    of ADM, said: “What are you gonna tell [Keough, the re-
    cently retired president of Coca-Cola], that we gotta [i.e.,
    have a] deal with . . . our two biggest competitors to fuck ya
    over[?]” Andreas, a principal figure in the lysine and citric-
    acid price-fixing conspiracies, also referred to Cargill’s pres-
    18                                                 No. 01-3565
    ident as a “friendly competitor” and mentioned an “under-
    standing between the companies that . . . causes us not
    to . . . make irrational decisions.” In a discussion with a Jap-
    anese businessman indicted along with Andreas for fixing
    the price of lysine, Andreas compared the relations between
    ADM and Cargill to those between Mitsubishi and Mitsui,
    two Japanese conglomerates widely believed to fix prices
    and allocate markets. Julie A. Shepard, Comment, “Using
    United States Antitrust Laws Against the Keiretsu as a
    Wedge Into the Japanese Market,” 6 Transnat’l Lawyer 345,
    349-50 (1993).
    A handwritten Cargill document refers under the heading
    “competitors” to “entry of new entrants (barriers) and will
    they play by the rules (discipline).” A price-fixing conspir-
    acy increases the attractiveness of entry into a market by
    creating a wedge between price and cost. And so conspira-
    tors will naturally worry whether, if there is entry, the new
    entrant will join rather than compete with the conspiracy
    and, if he refuses to join, whether the conspirators can pun-
    ish him in some way. This is not the only possible interpre-
    tation of the document, but it is a plausible one.
    Shortly after the FBI raided ADM’s headquarters seek-
    ing evidence of the company’s involvement in the lysine
    and citric-acid conspiracies, Terrence Wilson, the head of
    ADM’s corn processing division—the division responsible
    for HFCS as well as for the other two products—said he
    didn’t know “what other companies [the FBI] hit. . . .
    I don’t know . . . if they hit Staley or not.” Since Staley did
    not manufacture lysine or citric acid, but did of course man-
    ufacture HFCS, Wilson may have been expressing a concern
    that the FBI would uncover evidence of an HFCS price-
    fixing conspiracy as well. It is further worth noting that the
    alleged HFCS conspiracy began shortly after Wilson became
    head of ADM’s corn products division—which raises the
    question why, if as the defendants argue the 90 percent rule
    No. 01-3565                                                19
    and the other parallel behavior that is the plaintiffs’ evi-
    dence of a lack of price competition in the HFCS market
    were just the natural expression of the oligopolistic struc-
    ture of the market, this behavior should have begun when
    Wilson, later to be imprisoned for price fixing, took charge
    of ADM’s HFCS operations. There may be an answer (pure
    coincidence, perhaps, or a change in the structure of the
    HFCS industry that suddenly made tacit collusion more
    attractive)—a point with general application to our review
    of the evidence that favors the plaintiffs—but its adequacy
    presents a genuine issue of material fact and therefore can-
    not be determined on summary judgment. And in a civil
    case price fixing need be proved only by a preponderance
    of the evidence.
    There is some more evidence of the kind we’ve just been
    discussing, that is, evidence of explicit agreement, and other
    economic evidence as well that bolsters the plaintiffs’ case,
    evidence for example that ADM had significant ownership
    interests in two of the other defendants. But we can stop
    here because the evidence that we have summarized would
    have been enough to enable a reasonable jury to infer that
    the agreement to fix prices was express rather than tacit. The
    evidence is not conclusive by any means—there are alterna-
    tive interpretations of every bit of it—but it is highly sug-
    gestive of the existence of an explicit though of course co-
    vert agreement to fix prices.
    But there is one more piece of evidence that we do have to
    discuss because it was the subject of an evidentiary ruling
    that the plaintiffs challenge. After Andreas and Wilson were
    convicted and sent to prison for fixing the price of lysine,
    the plaintiffs deposed them and asked them whether they
    had fixed prices of HFCS as well. They (along with a third
    executive of ADM) refused to answer, on the ground that
    their answers might incriminate them. The general rule is
    20                                                 No. 01-3565
    that an adverse inference may be drawn from such a refusal
    in a civil case, Baxter v. Palmigiano, 
    425 U.S. 308
    , 318 (1976);
    Harris v. City of Chicago, 
    266 F.3d 750
    , 753 (7th Cir. 2001);
    LaSalle Bank Lake View v. Seguban, 
    54 F.3d 387
    , 389-91 (7th
    Cir. 1995), though of course the district judge retains his
    general power under Fed. R. Evid. 403 to exclude relevant
    evidence if its probative value is clearly outweighed by (so
    far as relevant here) its capacity to confuse the jury. Without
    referring to the rule, the district judge ruled the evidence of
    the deponents’ silence inadmissible because the three had
    refused to answer any substantive question, so that, the
    judge reasoned, no inference could be drawn from their
    refusal to answer questions about the alleged HFCS price-
    fixing conspiracy, at least in the absence of other evidence
    of such a conspiracy. But there was other evidence, as we
    have just seen.
    The deeper problem with the judge’s ruling is that it as-
    sumes that a person has carte blanche by virtue of the Fifth
    Amendment’s self-incrimination clause to refuse to answer
    questions. The assumption is incorrect. To be privileged by
    the Fifth Amendment to refuse to answer a question, the
    answer one would give if one did answer it (and answer it
    truthfully) must have some tendency to subject the person
    being asked the question to criminal liability. E.g., United
    States v. Apfelbaum, 
    445 U.S. 115
    , 128 (1980); United States v.
    Warner, 
    830 F.2d 651
    , 656 (7th Cir. 1987); United States v.
    Verkuilen, 
    690 F.2d 648
    , 654 (7th Cir. 1982); United States v.
    Reis, 
    765 F.2d 1094
    , 1096 (5th Cir. 1985) (per curiam);
    compare Sanchez v. Gilmore, 
    189 F.3d 619
    , 624 (7th Cir. 1999).
    The fact that Andreas and Wilson were in prison for having
    fixed prices for lysine and citric acid would not have author-
    ized them to invoke the Fifth Amendment if asked whether
    they had helped Richard III kill the little princes and bury
    them in the Tower of London. Andreas and Wilson had
    been convicted and sentenced for their role in the other
    No. 01-3565                                                  21
    price-fixing conspiracies and had exhausted their appellate
    remedies. They faced no further jeopardy—unless truthful
    answers to questions about the HFCS conspiracy would
    have tended to show that ADM had conspired to fix the
    price of that product as well. That would justify and explain
    their taking the Fifth and it would also entitle a jury to treat
    their refusal to answer as evidence that there indeed was
    such a conspiracy.
    The judge was correct that their refusal to answer could
    not be “imputed” to ADM, but imputation is not the issue.
    The issue is whether there was a conspiracy, and Andreas’s
    and Wilson’s refusal to answer the plaintiffs’ questions was
    one more piece of evidence that there was and that it in-
    volved their former employer, ADM, one of the defendants
    in this case. So it was admissible against ADM though not
    against the other defendants despite the coconspirator ex-
    ception to the hearsay rule. Fed. R. Evid. 801(d)(2)(E). The
    rule is applicable only to statements in furtherance of the
    conspiracy, and when Andreas and Wilson refused to speak
    the conspiracy was long over. Even if they were trying to
    conceal the conspiracy, this would not make their silence in
    furtherance of it, because efforts at concealing a conspiracy
    are not themselves part of the conspiracy. E.g., Grunewald v.
    United States, 
    353 U.S. 391
    , 404-06 (1957); United States v.
    Masters, 
    924 F.2d 1362
    , 1368 (7th Cir. 1991).
    In affirming Andreas’s conviction for his role in the other
    price-fixing conspiracies, this court remarked “an inexplica-
    ble lack of business ethics and an atmosphere of general
    lawlessness that infected the very heart of” ADM, whose
    senior executives “lied, cheated, embezzled, extorted and
    obstructed justice.” United States v. 
    Andreas, supra
    , 216 F.3d
    at 650. Since evidence of past crimes, or of other bad acts
    committed in the past, is inadmissible to prove that the
    defendant probably is guilty of whatever he is now being
    22                                                No. 01-3565
    charged with, merely because he has demonstrated a pro-
    pensity to violate the law, Fed. R. Evid. 404(b), ADM’s pre-
    vious misconduct cannot be used as evidence that it partici-
    pated in a conspiracy to fix the price of HFCS. But neither
    can it be used, as the defendants wish to use it in this case,
    to show that because the Justice Department has not moved
    against the alleged HFCS price-fixing conspiracy, there must
    not have been one. The Justice Department has limited re-
    sources; in the entire decade of the 1990s, it brought fewer
    than 200 civil antitrust cases, an average of fewer than 20
    per year. It brought more criminal antitrust cases, but the
    evidence in this case probably is not strong enough to estab-
    lish the defendants’ guilt beyond a reasonable doubt. With
    Andreas and Wilson in jail and a bright spotlight of suspi-
    cion shining on ADM and its competitors, the Department
    may have felt that there was little to be gained, so far as
    securing greater compliance with the Sherman Act was con-
    cerned, by suing these defendants for fixing the price of
    HFCS. It may also have felt that the antitrust class action bar
    had both the desire and the resources to prosecute such a
    suit vigorously, as indeed it has done. The evidence of the
    defendants’ guilt is weaker in this case than in the lysine
    and citric-acid conspiracy cases, but not so weak as to justify
    summary judgment in their favor.
    The upshot of our analysis of the evidence is that unless
    this opinion provides enough guidance to the parties to
    enable them to converge in their estimates of the likely out-
    come of a trial to the point at which settlement is feasible,
    there must be a trial; and we are naturally concerned about
    the practicability of a jury trial (the plaintiffs want and are
    entitled to a jury) in a case with such a staggeringly large
    record—the sealed exhibits alone fill 14 large boxes—that
    includes so much highly technical statistical material. We
    want to be realistic about the absorptive capacities of judges
    and juries. But actually the complexity of the case is largely
    No. 01-3565                                                  23
    illusory and a streamlined trial strikes us as eminently
    feasible. So far as the nonstatistical evidence is concerned, it
    is remarkable how little is in dispute. Most of the facts that
    we have recited in this opinion are not denied by the
    defendants; their quarrel with the plaintiffs is merely over
    the inferences to be drawn both from individual pieces of
    evidence and from the evidence considered as a whole. It is
    an undenied fact, for example, that an internal document of
    Cargill contains the statement “entry of new entrants (bar-
    riers) and will they play by the rules (discipline).” The only
    question is the meaning. When basic facts of the who-said-
    or-did-what-to-whom kind are agreed upon and only the
    inferences to be drawn from those facts are in dispute, the
    judge can streamline the trial by requiring the parties to
    stipulate to the undisputed facts and present the stipula-
    tions to the jury, rather than allowing the lawyers to bore
    everyone by eliciting uncontradicted facts by means of
    protracted direct examination and cross-examination of
    witnesses, as if they were dentists pulling teeth the old-fash-
    ioned way. See Federal Judicial Center, Manual for Complex
    Litigation § 21.47 (3d ed. 1995).
    Turning to the technical statistical evidence (not the data
    themselves, which for the most part are uncontested, but the
    inferences drawn from them by the use of statistical meth-
    odology), we recommend that the district judge use the
    power that Rule 706 of the Federal Rules of Evidence ex-
    pressly confers upon him to appoint his own expert witness,
    rather than leave himself and the jury completely at the
    mercy of the parties’ warring experts. See Manual for Com-
    plex Litigation, supra, § 21.51; Ford ex rel. Ford v. Long Beach
    Unified School District, No. 00-56438, 
    2002 WL 1059884
    , at *4
    (9th Cir. May 29, 2002); Meister v. Medical Engineering Corp.,
    
    267 F.3d 1123
    , 1125 and n. 3 (D.C. Cir. 2001); Walker v.
    American Home Shield Long Term Disability Plan, 
    180 F.3d 1065
    , 1071 (9th Cir. 1999). The main objection to this proce-
    24                                                  No. 01-3565
    dure and the main reason for its infrequency are that the
    judge cannot be confident that the expert whom he has
    picked is a genuine neutral. The objection can be obviated
    by directing the party-designated experts to agree upon a
    neutral expert whom the judge will then appoint as the
    court’s expert. See Daniel L. Rubinfeld, “Econometrics in the
    Courtroom,” 85 Colum. L. Rev. 1048, 1096 (1985). The neutral
    expert will testify (as can, of course, the party-designated
    experts) and the judge and jury can repose a degree of
    confidence in his testimony that it could not repose in that
    of a party’s witness. The judge and jurors may not under-
    stand the neutral expert perfectly but at least they will know
    that he has no axe to grind, and so, to a degree anyway, they
    will be able to take his testimony on faith.
    No doubt in view of the complexity of the case the judge
    will also want to bifurcate the trial, that is, to have a trial on
    liability first and only if the jury finds that the defendants
    violated the law to conduct a trial to determine the plain-
    tiffs’ damages.
    If these suggestions are followed, we think the case can be
    tried in a reasonable amount of time and be made compre-
    hensible to a jury.
    We do not mean to prejudge the outcome of the trial. We
    have construed the evidence as favorably to the plaintiffs as
    the record permits because that is how a grant of summary
    judgment in favor of defendants is reviewed. Maybe the
    defendants could convince a jury that the spin that their
    brief puts on the evidence is the correct one. We hold only
    that there is sufficient admissible evidence in support of the
    hypothesis of a price-fixing conspiracy to prevent the grant
    of summary judgment to the defendants. We trust that
    guided by this opinion the parties will make every effort to
    settle the case in advance of trial. And finally, although con-
    strained to disagree with the district judge’s decision to
    No. 01-3565                                               25
    grant summary judgment, we commend him for his pains-
    taking analysis of the record and for his patient shepherding
    of this formidable litigation.
    REVERSED AND REMANDED.
    A true Copy:
    Teste:
    _____________________________
    Clerk of the United States Court of
    Appeals for the Seventh Circuit
    USCA-97-C-006—6-18-02
    

Document Info

Docket Number: 01-3565

Judges: Per Curiam

Filed Date: 6/18/2002

Precedential Status: Precedential

Modified Date: 9/24/2015

Authorities (25)

Clamp-All Corporation v. Cast Iron Soil Pipe Institute , 851 F.2d 478 ( 1988 )

E.I. Du Pont De Nemours & Company v. Federal Trade ... , 729 F.2d 128 ( 1984 )

Jtc Petroleum Company v. Piasa Motor Fuels, Inc. , 190 F.3d 775 ( 1999 )

United States v. Thomas E. Verkuilen , 690 F.2d 648 ( 1982 )

United States v. Robert M. Warner , 830 F.2d 651 ( 1987 )

in-re-baby-food-antitrust-litigation-jacob-blinder-sons-inc-wiseway , 166 F.3d 112 ( 1999 )

Thomas E. Harris v. City of Chicago and Alex D. Ramos, ... , 266 F.3d 750 ( 2001 )

Hector Reuben Sanchez v. Jerry D. Gilmore, Warden, Pontiac ... , 189 F.3d 619 ( 1999 )

United States of America, Plaintiff-Appellee/cross-... , 216 F.3d 645 ( 2000 )

In Re Brand Name Prescription Drugs Antitrust Litigation. ... , 288 F.3d 1028 ( 2002 )

Reserve Supply Corporation v. Owens-Corning Fiberglas ... , 971 F.2d 37 ( 1992 )

Kimberly Hern Troupe v. The May Department Stores Company, ... , 20 F.3d 734 ( 1994 )

Lasalle Bank Lake View, an Illinois Banking Corporation v. ... , 54 F.3d 387 ( 1995 )

In Re Brand Name Prescription Drugs Antitrust Litigation , 186 F.3d 781 ( 1999 )

Meister, Brenda G. v. Medical Engineering , 267 F.3d 1123 ( 2001 )

in-re-citric-acid-litigation-7-up-bottling-coof-jasper-inc-and-varni , 191 F.3d 1090 ( 1999 )

rebel-oil-company-inc-a-nevada-corporation-auto-flite-oil-company-inc , 51 F.3d 1421 ( 1995 )

United States v. Alan Masters, Michael J. Corbitt, and ... , 924 F.2d 1362 ( 1991 )

In Re High Fructose Corn Syrup Antitrust Litigation , 156 F. Supp. 2d 1017 ( 2001 )

In Re Citric Acid Litigation , 996 F. Supp. 951 ( 1998 )

View All Authorities »